NRG-GY037
Phase III
OPEN TO ACCRUAL
A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab For High Risk Locally Advanced Cervical Cancer